Cara Therapeutics
CARA
#10362
Rank
โ‚ฌ6.83 M
Marketcap
4,48ย โ‚ฌ
Share price
-2.56%
Change (1 day)
-3.92%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2024 (TTM): โ‚ฌ6.59 Million

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ6.01 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ18.96 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ6.85 M-63.84%
2023 โ‚ฌ18.96 M-51.4%
2022 โ‚ฌ39.03 M91.95%
2021 โ‚ฌ20.33 M-81.49%
2020 โ‚ฌ0.10 B518.67%
2019 โ‚ฌ17.75 M50.77%
2018 โ‚ฌ11.77 M1450.68%
2017 โ‚ฌ0.75 M828.64%
2016 โ‚ฌ0.08 M-97.65%
2015 โ‚ฌ3.47 M33.15%
2014 โ‚ฌ2.61 M-69.85%
2013 โ‚ฌ8.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ77.62 B 1,291,044.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.89 B 879,625.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
โ‚ฌ0.45 M-92.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ63.48 M 955.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ84.57 M 1,306.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ97.43 M 1,520.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚ฌ0.54 M-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA